2026 Q3 Portfolio Activity
In 2026 Q3, ARMISTICE CAPITAL, LLC maintained a portfolio of 497 distinct positions. The most significant new addition was TELIX PHARMACEUTICAL LTD, now representing 0.22% of the total fund value. They heavily accumulated shares in ISHARES TR, increasing the position by 13.8%. The fund also reduced its exposure to MADRIGAL PHARMACEUTICALS INC by 68.0%.
Position History
hover any row below to update
Loading…
Total Positions
497
Quarter
2026 Q3
Top Holding
SPY (31.3%)
Top 10 Concentration
64.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 497
ARMISTICE CAPITAL, LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SPY
CALL
STATE STR SPDR ...
|
CALL Option | 31.31% | — |
#1
Prev: #—
|
9.5 |
—
|
3,350,000 | — |
NEW
|
3,350,000 | $2,554,810,500 |
$412.97
+76.8%
|
2014 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
IWM
CALL
ISHARES TR
|
CALL Option | 22.48% | — |
#2
Prev: #—
|
9.0 |
—
|
6,600,000 | — |
NEW
|
6,600,000 | $1,834,074,000 | 2019 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CYTK
CALL
CYTOKINETICS IN...
|
CALL Option | 2.07% | 1.59% |
#3
1
Prev: #4
|
4.8 |
—
|
1,030,000 | 67.3% |
P
S
|
2,560,000 | $168,729,600 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MDGL
CALL
MADRIGAL PHARMA...
|
CALL Option | 1.57% | — |
#4
Prev: #—
|
4.6 |
—
|
255,000 | — |
NEW
|
255,000 | $128,509,800 | 2016 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AGIO
CALL
AGIOS PHARMACEU...
|
CALL Option | 1.35% | 1.28% |
#5
1
Prev: #6
|
3.0 |
—
|
495,100 | 17.6% |
P
S
|
3,305,100 | $109,894,575 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SUPN
SUPERNUS PHARMA...
|
Healthcare | 1.34% | 1.51% |
#6
1
Prev: #5
|
1.0 |
—
|
-98,201 | -3.7% |
P
S
|
2,548,000 | $109,665,920 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PTCT
CALL
PTC THERAPEUTIC...
|
CALL Option | 1.26% | 0.66% |
#7
16
Prev: #23
|
3.5 |
—
|
930,000 | 140.9% |
P
S
|
1,590,000 | $103,000,200 | 2018 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 1.05% | 1.09% |
#8
3
Prev: #11
|
2.4 |
—
|
178,000 | 7.4% |
P
S
|
2,578,000 | $85,718,500 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 1.03% | 1.07% |
#9
3
Prev: #12
|
2.9 |
—
|
226,115 | 21.1% |
P
S
|
1,297,510 | $84,052,698 | 2018 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 0.98% | 1.10% |
#10
1
Prev: #9
|
2.4 |
—
|
29,413 | 5.5% |
P
S
|
565,251 | $80,175,202 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 0.95% | 1.25% |
#11
4
Prev: #7
|
0.9 |
—
|
-21,150 | -1.8% |
P
S
|
1,180,192 | $77,786,455 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 0.93% | 1.09% |
#12
2
Prev: #10
|
0.9 |
—
|
-282,771 | -18.0% |
P
S
|
1,289,768 | $75,941,540 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RIGL
RIGEL PHARMACEU...
|
Healthcare | 0.91% | 0.80% |
#13
5
Prev: #18
|
0.9 |
—
|
-136,000 | -8.1% |
P
S
|
1,536,000 | $73,958,400 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INCY
INCYTE CORP
|
Healthcare | 0.89% | 1.25% |
#14
6
Prev: #8
|
0.4 |
—
|
-299,960 | -33.3% |
P
S
|
600,045 | $72,815,461 | 2017 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NBIX
CALL
NEUROCRINE BIOS...
|
CALL Option | 0.87% | — |
#15
Prev: #—
|
3.8 |
—
|
500,000 | — |
NEW
|
500,000 | $70,920,000 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IRWD
IRONWOOD PHARMA...
|
Healthcare | 0.73% | 0.72% |
#16
4
Prev: #20
|
2.3 |
—
|
1,068,000 | 7.7% |
P
S
|
15,000,000 | $59,550,000 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.72% | 0.82% |
#17
Prev: #17
|
0.8 |
—
|
2,169 | 0.1% |
P
S
|
1,738,169 | $58,715,349 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.69% | 0.70% |
#18
3
Prev: #21
|
0.8 |
—
|
-128,000 | -8.2% |
P
S
|
1,436,000 | $56,377,360 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMVT
CALL
IMMUNOVANT INC
|
CALL Option | 0.67% | 0.57% |
#19
7
Prev: #26
|
2.8 |
—
|
425,000 | 35.4% |
P
S
|
1,625,000 | $54,892,500 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
FRPT
FRESHPET INC
|
Consumer Defensive | 0.63% | 0.91% |
#20
6
Prev: #14
|
0.3 |
—
|
-372,008 | -29.5% |
P
S
|
888,694 | $51,153,227 | 2015 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 0.57% | 1.89% |
#21
18
Prev: #3
|
0.2 |
—
|
-195,976 | -68.0% |
P
S
|
92,024 | $46,376,415 | 2016 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AMZN
AMAZON COM INC
|
Consumer Cyclical | 0.57% | 0.83% |
#22
6
Prev: #16
|
0.2 |
—
|
-98,735 | -34.7% |
P
S
|
185,827 | $46,298,797 | 2017 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 0.56% | 0.33% |
#23
26
Prev: #49
|
0.7 |
—
|
-1,300,000 | -18.5% |
P
S
|
5,724,000 | $46,078,200 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.54% | 0.57% |
#24
1
Prev: #25
|
0.7 |
—
|
32,000 | 1.8% |
P
S
|
1,768,000 | $44,429,840 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 0.53% | 0.84% |
#25
10
Prev: #15
|
0.7 |
—
|
-409,166 | -13.3% |
P
S
|
2,678,060 | $43,143,547 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 0.53% | 0.69% |
#26
4
Prev: #22
|
0.2 |
—
|
-33,073 | -36.8% |
P
S
|
56,736 | $43,021,207 | 2017 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TVTX
CALL
TRAVERE THERAPE...
|
CALL Option | 0.52% | 0.35% |
#27
18
Prev: #45
|
2.7 |
—
|
220,000 | 44.0% |
P
S
|
720,000 | $42,393,600 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.52% | 0.62% |
#28
4
Prev: #24
|
0.7 |
—
|
-24,000 | -3.3% |
P
S
|
700,000 | $42,381,500 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MLYS
CALL
MINERALYS THERA...
|
CALL Option | 0.49% | 0.34% |
#29
18
Prev: #47
|
3.2 |
—
|
560,000 | 53.8% |
P
S
|
1,600,000 | $40,208,000 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MDB
MONGODB INC
|
Technology | 0.46% | 0.51% |
#30
1
Prev: #31
|
0.7 |
—
|
-16,832 | -13.4% |
P
S
|
108,340 | $37,768,407 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GSK
GSK PLC
|
Healthcare | 0.43% | 0.19% |
#31
43
Prev: #74
|
3.2 |
—
|
424,000 | 141.3% |
P
S
|
724,000 | $34,875,080 | 2015 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 0.42% | 0.55% |
#32
4
Prev: #28
|
0.2 |
—
|
-292,000 | -20.4% |
P
S
|
1,136,000 | $34,409,440 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 0.42% | 0.24% |
#33
32
Prev: #65
|
3.2 |
—
|
35,082 | 71.9% |
P
S
|
83,886 | $34,110,564 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
OFIX
ORTHOFIX MED IN...
|
Healthcare | 0.42% | 0.36% |
#34
8
Prev: #42
|
2.2 |
—
|
360,000 | 11.0% |
P
S
|
3,624,000 | $34,101,840 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SNY
SANOFI SA
|
Healthcare | 0.42% | 0.56% |
#35
8
Prev: #27
|
0.2 |
—
|
-240,000 | -22.6% |
P
S
|
824,000 | $33,973,520 | 2016 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
UBER
UBER TECHNOLOGI...
|
Technology | 0.41% | 0.44% |
#36
2
Prev: #34
|
0.7 |
—
|
-11,259 | -2.3% |
P
S
|
486,649 | $33,340,323 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MSFT
MICROSOFT CORP
|
Technology | 0.41% | 0.37% |
#37
4
Prev: #41
|
0.7 |
—
|
-15,920 | -19.8% |
P
S
|
64,661 | $33,164,627 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 0.40% | 0.93% |
#38
25
Prev: #13
|
0.2 |
—
|
-93,000 | -50.8% |
P
S
|
90,000 | $33,037,200 | 2019 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.40% | 0.41% |
#39
3
Prev: #36
|
2.2 |
—
|
40,000 | 8.7% |
P
S
|
500,000 | $32,730,000 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GOOGL
ALPHABET INC
|
Communication Services | 0.40% | 0.55% |
#40
11
Prev: #29
|
0.2 |
—
|
-31,494 | -24.9% |
P
S
|
95,000 | $32,687,600 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SLDB
SOLID BIOSCIENC...
|
Healthcare | 0.40% | 0.52% |
#41
11
Prev: #30
|
2.2 |
—
|
218,000 | 5.1% |
P
S
|
4,496,000 | $32,506,080 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GTLB
GITLAB INC
|
Technology | 0.38% | 0.40% |
#42
5
Prev: #37
|
0.2 |
—
|
-413,437 | -38.5% |
P
S
|
660,704 | $31,218,264 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
FIVN
FIVE9 INC
|
Technology | 0.37% | 0.40% |
#43
5
Prev: #38
|
0.1 |
—
|
-660,000 | -43.0% |
P
S
|
876,000 | $29,792,760 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AXGN
AXOGEN INC
|
Healthcare | 0.36% | 0.44% |
#44
9
Prev: #35
|
0.6 |
—
|
-83,000 | -10.7% |
P
S
|
692,000 | $29,008,640 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XRAY
DENTSPLY SIRONA...
|
Healthcare | 0.35% | 0.48% |
#45
12
Prev: #33
|
0.6 |
—
|
-436,000 | -11.9% |
P
S
|
3,236,000 | $28,670,960 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NTLA
INTELLIA THERAP...
|
Healthcare | 0.35% | 0.31% |
#46
5
Prev: #51
|
3.1 |
—
|
864,000 | 57.6% |
P
S
|
2,364,000 | $28,509,840 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
WYNN
WYNN RESORTS LT...
|
Consumer Cyclical | 0.35% | 0.31% |
#47
5
Prev: #52
|
2.6 |
—
|
95,971 | 36.8% |
P
S
|
357,036 | $28,359,369 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TMCI
TREACE MED CONC...
|
Healthcare | 0.35% | 0.31% |
#48
5
Prev: #53
|
1.1 |
—
|
no change | no change |
P
S
|
6,364,000 | $28,256,160 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
FDMT
4D MOLECULAR TH...
|
Healthcare | 0.34% | 0.33% |
#49
1
Prev: #50
|
0.6 |
—
|
-50,000 | -2.5% |
P
S
|
1,950,000 | $27,904,500 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BABA
ALIBABA GROUP H...
|
Consumer Cyclical | 0.33% | 0.20% |
#50
21
Prev: #71
|
2.6 |
—
|
82,000 | 48.8% |
P
S
|
250,000 | $26,885,000 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-50 of 497 holdings